Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Fitish

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Fitish head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 93 · Grade C

Fitish

Visit Fitish Full brief →

FDA warning letter, June 2026 — issued to FITISH. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Fitish a bad call — it's best for people who want portal-based compounded glp-1 care and will confirm prescription-specific billing and refund terms. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
77
Transparency
90
88
Access Breadth
93
96
Clinical Oversight
92
73
Track Record
88
60
CoreAge RxBrief Score 94 · 75Fitish

Price, coverage & the tracker

CoreAge RxFitish
Brief Score94/100 (A)75/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current price

Earlier listing: $219/mo compounded semaglutide; current product quote could not be reconfirmed.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier observed $219/mo compounded; current semaglutide product page was unavailable during review

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$339 per monthly supply

Compounded tirzepatide; consultation, medication if approved and shipping advertised as included.

Full price details

$339 for a monthly supply of compounded tirzepatide; advertised consult, medication if approved and shipping included

CoverageUS only; restrictions by state, confirmed at intakeConfirm current prescription-specific state access; no complete coverage list verified
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Fitish: Tirzepatide is advertised at $339 per monthly supply with consultation and shipping. Current semaglutide quote is unconfirmed. Clarify refund, renewal and pharmacy details.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.